Pfizer, BioNTech Seek To Nix Moderna Vax IP Suit, Countersue
By Dave Simpson · December 5, 2022, 10:50 PM EST
Several Moderna patents related to technology behind the mRNA platform in COVID-19 vaccines are invalid, rival vaccine-makers Pfizer Inc. and BioNTech told a Massachusetts federal judge on Monday in a bid...
To view the full article, register now.